GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

InBody Co 041830.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

40,550

-3.57%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About InBody Co

Its shares trade on KOSDAQ under the ticker 041830.KQ. It has been listed since 14 December 2000. In the fiscal year to 31 December 2025, it reported revenue of ₩233.95bn and net income of ₩30.63bn. At that date it held total assets of ₩361.06bn and shareholders' equity of ₩317.85bn.

InBody Co., Ltd. engages in the manufacture and sale of medical equipment. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-12-14. The firm mainly produces body composition analyzers under the brand names of InBody and Lookin’Body. The firm mainly produces body composition analyzers under the brand name InBody and Lookin’Body. Its InBody series products include InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10 and InBody J10. Its Lookin' series products include Lookin’Body3.0 and Lookin’Body Basic, which are used for measuring proteins, minerals, fats, moistures and others. The company also provides body mass index (BMI) measuring devices under the brand name of BSM. The firm distributes its products within domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
14 Dec 2000

Leadership

Pay as last reported

  • Gi Cheol ChaChairman, Chief Executive Officer, since 2024
  • Gyeong Ho YooVice President, Director, since 2010
  • Taek Seon KimInternal Auditor, since 2008
  • Jae Tak LeeIR Contact Officer

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Seoul, South Korea
  • Produces body composition analyzers under InBody and Lookin'Body brands
  • Offers a range of products including InBody720, InBody520, and Lookin'Body3.0

Weaknesses

  • Limited product range beyond body composition analyzers
  • Reliance on domestic and overseas market distribution
  • No mention of financial data or analytics services

Opportunities

  • Expansion into new markets for body composition analyzers
  • Potential growth in health care sector demand for body composition analysis
  • Opportunity to diversify product offerings beyond current range

Threats

  • Competition from other medical equipment manufacturers
  • Dependence on specific product lines for revenue
  • Potential regulatory changes in health care industry

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.